From Italy to Saint Louis: Adaptin to COVID-19
Authors: Abatecola Angela Marie
Date: 2020
Scope of interest: Covid-19
06 99 39
Recup number
You may also be interested in:
Extracorporealphotochemotherapy in the treatment of acute and chronic GvHD: experience from Rome Transplant Network.
Authors: A. Lanti , S.D. Spurio , A.S. Ferraro, E. D’Alessandro,O.M. Chiru ,E.Fiorelli , R.Massarelli ,L. Cudillo, A. Picardi , E. Ceresoli , B. Mariotti ,I. Provenzano, G. Adorno ,G. Isacchi ,W.Arcese
Date: 2011
Scope of interest: Hematology/Transfusion Medicine
Read details
Tocilizumab for patients with COVID-19pneumonia. The single-arm TOCIVID-19 prospective trial.
Authors: Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy.
Date: 2020
Scope of interest: sars cov 2 therapy
Read details
Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First ItalianζoRk Study (BRIVAFIRST).
Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Chiesa V, Dainese F, De Maria G, Didato G, Falcicchio G, Fanella M, Ferlazzo E, Fisco G, Gangitano M, Giallonardo AT, Giorgi FS, La Neve A, Mecarelli O, Montalenti E, Piazza F, Pulitano P, Quarato PP, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership.
Date: 2021
Scope of interest: Epilepsy
Read details
What to do to
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide
